MedPath

Rsp Systems A/S

🇩🇰Denmark
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

16

Active:0
Completed:12

Trial Phases

1 Phases

Not Applicable:16

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Not Applicable
16 (100.0%)

Study of a Non-invasive Glucose Measuring Device

Not Applicable
Completed
Conditions
Diabetes Mellitus
First Posted Date
2023-05-09
Last Posted Date
2023-08-14
Lead Sponsor
RSP Systems A/S
Target Recruit Count
50
Registration Number
NCT05851469
Locations
🇩🇪

Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany

A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings

Not Applicable
Completed
Conditions
Diabetes Mellitus
First Posted Date
2020-08-19
Last Posted Date
2023-11-18
Lead Sponsor
RSP Systems A/S
Target Recruit Count
173
Registration Number
NCT04518813
Locations
🇩🇪

Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany

Calibration of a Non-invasive Glucose Measurement Device and Assessment of Its Performance in the Hypoglycemic Range in Patients With Type 1 Diabetes

Not Applicable
Completed
Conditions
Diabetes Mellitus
First Posted Date
2019-10-15
Last Posted Date
2020-10-08
Lead Sponsor
RSP Systems A/S
Target Recruit Count
15
Registration Number
NCT04126759
Locations
🇩🇰

Steno Diabetes Center Copenhagen (SDCC), Gentofte, Denmark

Device Accuracy of Non-invasive Glucose Measurements in Ethnic Skin

Not Applicable
Withdrawn
Conditions
Diabetes Mellitus
First Posted Date
2019-08-19
Last Posted Date
2023-11-18
Lead Sponsor
RSP Systems A/S
Registration Number
NCT04060693
Locations
🇬🇧

Centre for Rare Disease ITM, Heritage Building (Queen Elizabeth Hospital Birmingham), Birmingham, Edgbaston, United Kingdom

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use

Not Applicable
Completed
Conditions
Diabetes Mellitus
First Posted Date
2019-07-25
Last Posted Date
2020-10-08
Lead Sponsor
RSP Systems A/S
Target Recruit Count
10
Registration Number
NCT04033042
Locations
🇩🇪

Institut für Diabetes-Technologie Forschungs- und Entwicklungs-gesellschaft mbH an der Universität Ulm (IDT), Ulm, Germany

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.